[go: up one dir, main page]

ES2197818A1 - 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes. - Google Patents

2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes.

Info

Publication number
ES2197818A1
ES2197818A1 ES200201331A ES200201331A ES2197818A1 ES 2197818 A1 ES2197818 A1 ES 2197818A1 ES 200201331 A ES200201331 A ES 200201331A ES 200201331 A ES200201331 A ES 200201331A ES 2197818 A1 ES2197818 A1 ES 2197818A1
Authority
ES
Spain
Prior art keywords
tetraazaporphycene
alkenyl
aryl
intermediate compound
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200201331A
Other languages
English (en)
Other versions
ES2197818B1 (es
Inventor
Bilbao Jose Ignacio Borell
Gomez Salvador Borros
Guardia Carles Colominas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Quimic de Sarria CETS Fundacio Privada
Original Assignee
Institut Quimic de Sarria CETS Fundacio Privada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Quimic de Sarria CETS Fundacio Privada filed Critical Institut Quimic de Sarria CETS Fundacio Privada
Priority to ES200201331A priority Critical patent/ES2197818B1/es
Priority to AU2003232859A priority patent/AU2003232859A1/en
Priority to PCT/ES2003/000267 priority patent/WO2003104237A1/es
Publication of ES2197818A1 publication Critical patent/ES2197818A1/es
Application granted granted Critical
Publication of ES2197818B1 publication Critical patent/ES2197818B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)

Abstract

2,7,12,17 Alquenil, aril y heteroaril derivados del 3,6,13,16- tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes. La presente invención desarrolla la síntesis de sistemas 3,6,13,16-tetraazaporficénicos de fórmula general (1) donde R puede ser un grupo alquenilo (vinilo o estirilo), o un grupo arilo el cual puede estar no sustituido o sustituido por uno o varios grupos alquilo C1-6, alcoxilo C1-6, amino, mono- o dialquilamino o hidroxicarbonilo, o un grupo heteroarilo (tienilo o piridilo) el cual puede estar no sustituido o sustituido por uno o más grupos alquilo C1-6.
ES200201331A 2002-06-11 2002-06-11 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes. Expired - Fee Related ES2197818B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES200201331A ES2197818B1 (es) 2002-06-11 2002-06-11 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes.
AU2003232859A AU2003232859A1 (en) 2002-06-11 2003-06-03 2,7,12,17 alkenyl, aryl and heteroaryl derived from 3,6,13,16-tetraazaporphycene, method, intermediate compound and corresponding utilizations
PCT/ES2003/000267 WO2003104237A1 (es) 2002-06-11 2003-06-03 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200201331A ES2197818B1 (es) 2002-06-11 2002-06-11 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes.

Publications (2)

Publication Number Publication Date
ES2197818A1 true ES2197818A1 (es) 2004-01-01
ES2197818B1 ES2197818B1 (es) 2005-02-01

Family

ID=29724722

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200201331A Expired - Fee Related ES2197818B1 (es) 2002-06-11 2002-06-11 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes.

Country Status (3)

Country Link
AU (1) AU2003232859A1 (es)
ES (1) ES2197818B1 (es)
WO (1) WO2003104237A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275416A1 (es) * 2005-07-15 2007-06-01 Institut Quimic De Sarria Cets Derivados halogenados de 4h, 5h-tieno (3-2-b: 4,5) pirirrolles y procedimiento y utilizaciones correspondientes.

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE502005009802D1 (de) 2005-11-10 2010-08-05 Novaled Ag Dotiertes organisches Halbleitermaterial
US7919010B2 (en) 2005-12-22 2011-04-05 Novaled Ag Doped organic semiconductor material
EP1837927A1 (de) 2006-03-22 2007-09-26 Novaled AG Verwendung von heterocyclischen Radikalen zur Dotierung von organischen Halbleitern
ATE394800T1 (de) 2006-03-21 2008-05-15 Novaled Ag Heterocyclisches radikal oder diradikal, deren dimere, oligomere, polymere, dispiroverbindungen und polycyclen, deren verwendung, organisches halbleitendes material sowie elektronisches bauelement
DE102007012794B3 (de) 2007-03-16 2008-06-19 Novaled Ag Pyrido[3,2-h]chinazoline und/oder deren 5,6-Dihydroderivate, deren Herstellungsverfahren und diese enthaltendes dotiertes organisches Halbleitermaterial
DE102007018456B4 (de) 2007-04-19 2022-02-24 Novaled Gmbh Verwendung von Hauptgruppenelementhalogeniden und/oder -pseudohalogeniden, organisches halbleitendes Matrixmaterial, elektronische und optoelektronische Bauelemente
EP3076451B1 (de) 2007-04-30 2019-03-06 Novaled GmbH Oxokohlenstoff, pseudooxokohlenstoff- und radialenverbindungen sowie deren verwendung
EP1990847B1 (de) 2007-05-10 2018-06-20 Novaled GmbH Verwendung von chinoiden Bisimidazolen und deren Derivaten als Dotand zur Dotierung eines organischen halbleitenden Matrixmaterials
DE102007031220B4 (de) 2007-07-04 2022-04-28 Novaled Gmbh Chinoide Verbindungen und deren Verwendung in halbleitenden Matrixmaterialien, elektronischen und optoelektronischen Bauelementen
US8057712B2 (en) 2008-04-29 2011-11-15 Novaled Ag Radialene compounds and their use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012636A1 (en) * 1991-01-29 1992-08-06 Cytopharm, Inc. Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy
WO1993000087A1 (en) * 1991-06-28 1993-01-07 Cytopharm, Inc. Porphycene compounds for photodynamic therapy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6906050B2 (en) * 2001-05-31 2005-06-14 Miravant Pharmaceuticals, Inc. Substituted porphyrin and azaporphyrin derivatives and their use in photodynamic therapy, radioimaging and MRI diagnosis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992012636A1 (en) * 1991-01-29 1992-08-06 Cytopharm, Inc. Derivatives of porphycene of direct utility in photodynamic therapy or as intermediates for synthesis of photoactivatable dyes suitable for photodynamic therapy
WO1993000087A1 (en) * 1991-06-28 1993-01-07 Cytopharm, Inc. Porphycene compounds for photodynamic therapy

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2275416A1 (es) * 2005-07-15 2007-06-01 Institut Quimic De Sarria Cets Derivados halogenados de 4h, 5h-tieno (3-2-b: 4,5) pirirrolles y procedimiento y utilizaciones correspondientes.

Also Published As

Publication number Publication date
WO2003104237A1 (es) 2003-12-18
ES2197818B1 (es) 2005-02-01
AU2003232859A1 (en) 2003-12-22

Similar Documents

Publication Publication Date Title
ES2197818A1 (es) 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes.
DE60234510D1 (de) 1h-indazolverbindungen die jnk hemmen
CY1115302T1 (el) Ενωση οξαζολιου και φαρμακευτικη συνθεση
HRP20070132T3 (en) Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
MXPA04001016A (es) Derivados de sulfonamida como inhibidores de la gamma secretasa.
NO20052887L (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
ATE522525T1 (de) Arylsubstituierte pyrazolamidverbindungen, die als kinase-inhibitoren von nutzen sind
ATE401312T1 (de) Pyrimidin-5-carboxamid-derivate
ATE417038T1 (de) Phenylpyridincarbonyl piperazinderivate
ATE282630T1 (de) Dolastatin-derivate
PT1414797E (pt) Inibidores da polimerase do vírus da hepatite c com uma estrutura heterobicíclica
CO5611195A2 (es) Novedosos inhibidores de la gamma secretasa
WO2009109991A3 (en) Novel hydrazide containing tyrosine kinase inhibitors
TW200519538A (en) Resist compound and radiation-sensitive composition
CY1106716T1 (el) 4-υποκαθισταμενα παραγωγα πιπεριδινης
PE20010751A1 (es) Quinolin-2-ona como inhibidores de las proteinas resistentes a multiples farmacos
ATE503746T1 (de) Neue imidazolidinderivate
GT200300284A (es) Derivados de 3h-quinazolin-4-ona
DE602006005349D1 (de) Verfahren zur herstellung von hydrazon-derivaten
CO5580721A2 (es) Composicion fungicida basada en al menos un derivado de piridilmetilbenzamida y al menos un derivado de ditiocarbamato
MXPA04003195A (es) Composiciones estabilizadoras termicas para polimeros de vinilo que contienen halogeno.
NO20064329L (no) Derivater av heteroaryl-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse derav som FAAH enzyminhibitorer
CO5700777A2 (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la recaptacion de serotonina
BR0308935A (pt) Inibidor de fosfodiesterase iv contendo derivado de piridilacrilamida
CY1106940T1 (el) Μονοσακχαριδικα παραγωγα της αβερμεκτινης β1

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20040101

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2197818B1

Country of ref document: ES

FD1A Patent lapsed

Effective date: 20100315